BioNTech (ADRs) Aktie

318,60EUR
-3,70EUR
-1,15%
08:18:26

WKN: A2PSR2 / ISIN: US09075V1026 / Symbol: BNTX

  Kaufen  
Verkaufen
oder
Werbung

BioNTech (ADRs) Aktien News

01.11.21
BioNTech founders: COVID is going to become more manageable (Deutsche Welle)
01.11.21BioNTech to Present New Clinical Data from First-in-Class CAR-T Program BNT211 in Late-breaking Session at 36th SITC Annual Meeting (GlobeNewswire)
01.11.21
: What to expect from Tuesday’s CDC meeting about BioNTech and Pfizer’s COVID-19 shots for young children (MarketWatch)
04.11.21
Why BioNTech Stock Is Falling Today (MotleyFool)
05.11.21
Why BioNTech Stock Is Plunging Today (MotleyFool)
08.11.21
Is a Surprise Coming for BioNTech (BNTX) This Earnings Season? (Zacks)
08.11.21
Why BioNTech Stock Is Bouncing Back Today (MotleyFool)
08.11.21
Is a Beat in Store for BioNTech (BNTX) This Earnings Season? (Zacks)
09.11.21BioNTech Announces Third Quarter 2021 Financial Results and Corporate Update (GlobeNewswire)
09.11.21
COVID vaccine developer BioNTech sees profits rise (EN, Chinapost)
09.11.21
BioNTech lifts revenue forecast as Covid vaccine orders climb (Financial Times)
09.11.21
Coronavirus Update: Pfizer and BioNTech seek backing of COVID-19 booster for those 18 and over, as U.S. deaths continue to average 1,200 a day (MarketWatch)
09.11.21
BioNTech stock reverses lower after earnings report, in which profit and revenue beat expectations (Market Watch)
09.11.21
Why BioNTech Is Tumbling Today (MotleyFool)
10.11.21
BioNTech SE (BNTX) Q3 2021 Earnings Call Transcript (MotleyFool)
10.11.21
COVID: Germany recommends only BioNTech-Pfizer shot to under 30s (Deutsche Welle)
19.11.21
Will Pfizer and BioNTech Win Authorization for Boosters for All Adults? (MotleyFool)
19.11.21BioNTech Receives FDA Fast Track Designation for its FixVac Candidate BNT111 in Advanced Melanoma (GlobeNewswire)
19.11.21
6-K: Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act (rss)
19.11.21
: Pfizer, BioNTech COVID-19 vaccine authorized for use in Canada in children 5 to 11 years old (MarketWatch)
19.11.21
Pfizer, BioNTech COVID-19 vaccine authorized in Canada for children 5 to 11 years of age (Market Watch)
19.11.21
Why BioNTech Stock Was Blasting 20% Higher This Week (MotleyFool)
22.11.21Follow-Up Data from Phase 3 Trial Of Pfizer-BioNTech COVID-19 Vaccine Support Safety and High Efficacy in Adolescents 12 Through 15 Years of Age (GlobeNewswire)
22.11.21
Follow up data from Phase III trial of Pfizer-BioNTech COVID-19 vaccine support safety in kids 12-15 (MarketWatch)
22.11.21
Pfizer and BioNTech say late-stage trial shows vaccine effective for 12- to 15-year-olds (Market Watch)
25.11.21Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY® in Children 5 to under 12 Years of Age in the European Union (GlobeNewswire)
25.11.21
BioNTech SE : Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY® in Children 5 to under 12 Years of Age in the European Union (Investegate)
26.11.21
6-K: Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act (rss)
27.11.21
EU regulator approves BioNTech-Pfizer vaccine for 5-11 age group (Deutsche Welle)
29.11.21
BioNTech is Already Working on Vaccine for the Covid Variant Omicron (Novinite)
29.11.21
Why BioNTech Is Beating the Market Today (MotleyFool)

BioNTech (ADRs) News

BioNTech (ADRs) News: auf dieser Seite finden Sie alle BioNTech (ADRs) News und Nachrichten zur BioNTech (ADRs) Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch BioNTech (ADRs) News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um BioNTech (ADRs) News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.
Werbung
finanzen.net zero
finanzen.net zero

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln